Identification of oligonucleotides for the capture, detection and quantitation of hepatitis B viral DNA
OwnerVenkatakrishna Shyamalainventor
Life of this patent
Estimating the term…
Abstract
Hepatitis B virus capture oligonucleotides, primers and probes derived from conserved regions of the hepatitis B virus genome are disclosed. Also disclosed are nucleic acid-based assays using the capture oligonucleotides, primers and probes.
Claims51
An isolated oligonucleotide not more than 60 nucleotides in length comprising:
- (a) a nucleotide sequence of at least 10 contiguous nucleotides from a sequence selected from the group consisting of SEQ ID NOs:
- 1-10, 13, 14, and 15;
- (b) a nucleotide sequence having 90% sequence identity to a nucleotide sequence of (a);
- or
- (c) complements of (a) and (b).
A method for detecting Hepatitis B virus (HBV) infection in a biological sample, the method comprising:
- isolating nucleic acids from a biological sample suspected of containing HBV;
- amplifying the nucleic acids using at least two primers wherein (a) each of the primers is not more than about 60 nucleotides in length and comprises a nucleotide sequence of at least 10 contiguous nucleotides from a sequence selected from the group consisting of SEQ ID NOs:
- 5, 6, 8, 9, and 10 or (b) primers having 90% sequence identity to a nucleotide sequence of (a), wherein each of the two primers is sufficiently complementary to a portion of the sense and antisense strands, respectively, of the isolated nucleic acid to hybridize therewith;
- and
- detecting the presence of the amplified nucleic acids as an indication of the presence or absence of HBV in the sample.
A method for detecting Hepatitis B virus (HBV) infection in a biological sample, the method comprising:
- (a) contacting a solid support with one or more capture nucleic acids selected from the group consisting of SEQ ID NOs:
- 1, 2, 3, and 4 under conditions wherein the capture nucleic acids become associated with the solid support,
- (b) contacting the solid support of (a) with the biological sample under hybridizing conditions wherein target nucleic acid strands from HBV when present hybridize with the capture nucleic acids;
- and
- (c) separating the solid support of (b) from the sample;
- (d) amplifying the nucleic acids using a sense primer comprising SEQ ID NO:5 and at least two antisense primers comprising SEQ ID NOs:
- 6 and 8 or SEQ ID Nos:
- 9 and 10, wherein the sense and antisense primers are sufficiently complementary to a portion of the sense and antisense strands, respectively, of the isolated nucleic acid to hybridize therewith;
- and
- (e) detecting the presence of the amplified nucleic acids as an indication of the presence or absence of HBV in the sample.
Isolated oligonucleotides for use in capturing HBV nucleic acids comprising one or more oligonucleotides, wherein each of the oligonucleotides is not more than about 60 nucleotides in length and comprises a nucleotide sequence of at least 10 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4.
Primers for use in detecting HBV nucleic acids comprising sense and antisense primers, wherein the sense and the antisense primers are not more than about 60 nucleotides in length and comprise a nucleotide sequence of at least 10 contiguous nucleotides wherein the sense primer comprises SEQ ID NO:5 and the antisense primers are selected from the group consisting of SEQ ID NOs:
- 6, 8, 9 and 10.
A kit for detecting Hepatitis B virus (HBV) infection in a biological sample, the kit comprising:
- capture nucleic acids comprising one or more oligonucleotides, wherein each of the oligonucleotides is not more than about 60 nucleotides in length and comprises a nucleotide sequence of at least 10 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4.;
- primer oligonucleotides wherein the primer oligonucleotides are not more than about 60 nucleotides in length and comprise a nucleotide sequence of at least 10 contiguous nucleotides from a sequence selected from the group consisting of SEQ ID NOs:
- 5, 6, 8, 9, and 10;
- and
- written instructions for identifying HBV infection.
Dependencies are inferred from the claim text.